Your Patients Are Struggling to Fill Their Inhalers — Here's How You Can Help
As a provider, you've likely heard from patients who can't find their Fluticasone/Salmeterol inhaler. Whether they're prescribed Advair Diskus, Wixela Inhub, or AirDuo RespiClick, the ongoing supply disruptions have turned routine prescription refills into a source of anxiety for patients with asthma and COPD.
This guide offers a practical, step-by-step approach to helping your patients navigate availability challenges — from real-time stock checking to therapeutic alternatives and cost considerations.
Current Availability Landscape
The Fluticasone/Salmeterol supply picture in 2026 is mixed. ASHP has tracked intermittent shortages primarily affecting generic dry powder inhaler formulations. The key points:
- Wixela Inhub: Intermittent availability. Certain strengths (particularly 250/50 mcg) have been more affected.
- Brand-name Advair Diskus: Generally available but at premium pricing ($250–$500+), which is prohibitive for many patients.
- AirDuo RespiClick: Less affected by the shortage but requires a new prescription (not AB-rated to Advair Diskus).
- Advair HFA (MDI): Available in many areas but uses a different device that requires patient re-education on technique.
Availability varies significantly by geography and even by individual pharmacy location. What's out of stock at one pharmacy may be available two miles away.
Why Patients Can't Find Their Medication
Understanding the root causes helps you communicate effectively with frustrated patients:
- Manufacturing complexity: Inhaler devices require specialized production facilities. Only a few manufacturers (GSK, Viatris, Teva) produce Fluticasone/Salmeterol products.
- Supply chain vulnerabilities: Raw material sourcing, propellant availability, and logistics disruptions all affect the inhaler supply chain.
- High demand: With 25+ million asthma patients and 16+ million COPD patients in the U.S., demand for ICS/LABA inhalers consistently strains supply during production disruptions.
- Pharmacy stocking patterns: Large chain pharmacies order based on predicted demand and may not carry all strengths or formulations. Independent pharmacies often use different wholesalers and may have different stock availability.
For a detailed patient-facing explanation, share our post on why Fluticasone/Salmeterol is hard to find.
What Providers Can Do: 5 Practical Steps
Step 1: Direct Patients to Real-Time Stock Tools
The single most impactful thing you can do is point patients to Medfinder for Providers. This tool allows patients (and your staff) to check which pharmacies currently have Fluticasone/Salmeterol in stock, by ZIP code and formulation.
Consider integrating this into your discharge instructions or after-visit summaries when prescribing this medication. A simple line like "Check medfinder.com to find a pharmacy with your inhaler in stock" can save patients hours of phone calls.
Step 2: Prescribe with Flexibility
When writing prescriptions for Fluticasone/Salmeterol, consider the following strategies:
- Allow generic substitution: Unless clinically necessary, avoid "dispense as written" for Advair Diskus. This allows pharmacists to fill with Wixela Inhub when available.
- Include alternative NDCs: When e-prescribing, you can add a note about acceptable alternatives.
- Write backup prescriptions: Consider providing a second prescription for an alternative ICS/LABA (e.g., generic Budesonide/Formoterol) that the patient can fill if Fluticasone/Salmeterol is unavailable. Clearly note that only one should be filled.
Step 3: Know the Formulation Landscape
Be ready to discuss different Fluticasone/Salmeterol products with patients:
- Advair Diskus ↔ Wixela Inhub: Identical active ingredients and strengths. Pharmacist can substitute.
- AirDuo RespiClick: Same active ingredients but different delivered doses. Requires new Rx. Different DPI device — ensure patient education.
- Advair HFA: MDI formulation. Different dosing convention. Requires spacer for optimal delivery. Good option for patients who struggle with DPI technique.
Step 4: Have a Therapeutic Alternative Ready
Identify one or two backup ICS/LABA options for your Fluticasone/Salmeterol patients before they face a fill failure. Recommended alternatives:
- Generic Budesonide/Formoterol (Symbicort generic): Most cost-effective option ($30–$80 with coupons). Approved for asthma and COPD. Formoterol's rapid onset is a clinical plus.
- Breo Ellipta (Fluticasone Furoate/Vilanterol): Once-daily dosing. Same drug class. May improve adherence. Not yet generic ($300–$400).
- Dulera generic (Mometasone/Formoterol): Asthma only — not for COPD patients. Affordable generic option.
For a comprehensive clinical comparison, see our provider shortage briefing.
Step 5: Address Cost Barriers Proactively
During shortages, patients may be forced to fill at pharmacies charging higher prices, or switch to formulations with different insurance coverage. Proactive cost management helps:
- Copay cards: GSK Copay Assistance (Advair — as low as $10/month), Viatris Wixela Savings Card (as low as $10/fill). Commercial insurance required.
- Discount coupons: GoodRx, SingleCare, and other platforms offer significant savings on Wixela Inhub ($64+) and generic alternatives.
- Patient assistance programs: GSK For You and Viatris PAP for uninsured/underinsured patients — free medication.
- Insurance navigation: Help patients understand their formulary. Many plans prefer generic Symbicort or Wixela over brand-name Advair.
Direct patients to our savings guide: How to Save Money on Fluticasone/Salmeterol. For a clinical perspective on cost strategies, see our provider's guide to helping patients save.
Therapeutic Alternatives at a Glance
A quick reference for common switches:
- Advair Diskus 100/50 → Symbicort 80/4.5 (2 puffs BID) or Breo Ellipta 100/25 (1 inh daily)
- Advair Diskus 250/50 → Symbicort 160/4.5 (2 puffs BID) or Breo Ellipta 100/25–200/25 (1 inh daily)
- Advair Diskus 500/50 → Symbicort 160/4.5 (2 puffs BID, higher ICS dose) or Breo Ellipta 200/25 (1 inh daily)
Note: These are approximate equivalencies. Adjust based on clinical response and patient-specific factors.
Workflow Tips for Your Practice
- Flag affected patients: Run a report of patients currently prescribed Fluticasone/Salmeterol. Proactively reach out before they run into fill failures.
- Standardize communication: Create a template message (patient portal, SMS) explaining the shortage situation and providing Medfinder link and alternative options.
- Train front office staff: Ensure your team knows to check Medfinder when patients call about fill issues, rather than defaulting to "call your pharmacy."
- Document alternative plans: Note backup medications in the chart so any covering provider can act quickly if the primary inhaler can't be filled.
- Monitor ASHP updates: Subscribe to ASHP shortage alerts for this medication to stay current on supply changes.
Final Thoughts
Helping patients navigate medication shortages is increasingly part of clinical practice. For Fluticasone/Salmeterol, the combination of limited manufacturers, complex inhaler devices, and high patient demand creates a supply environment that requires provider engagement beyond writing a prescription.
By leveraging tools like Medfinder for Providers, prescribing with flexibility, and proactively planning for alternatives, you can help your patients maintain continuity of care — even when supply is uncertain.
Share these patient-facing resources:
%2C%20Color%3DOriginal.png)
